| Methods |
RCT.Multi‐institutional and multinational.
Placebo controlled,double blind,parallel design. |
| Participants |
772 male and female patients
inclusion criteria: >18 years. Urinary freq. more than 8 times in 24 hours. Urge incontinence 5 times in a week.
Exclusion criteria: Lower urinary tract surgery in last 6 monthsInt.cystitisUrethral syndrome, Painful bladder syndrome, Overflow incontinence
Total urinary volume of more than 3 litres. Significant hepatic and renal insufficiency. Pregnant women |
| Interventions |
Group 1: tolterodine ER 4 mg once a day
Group2: placebo. |
| Outcomes |
No. of incontinence episodes
No. of micturitions in 24 hours
Volume voided per micturition |
| Notes |
The data is reported in mean and range and hence can not be analysed by meta analysis |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Low risk |
A ‐ Adequate |
